Life sciences
-
How to keep building labs while prices and supply chains are volatile
COMMENT Linesight’s Nigel Barnes on the 10/80/10 rule that can help the UK boost life sciences space
-
Life sciences shows resilience to 2022 headwinds
Eyes are on London schemes as OxCam lab supply dwindles
-
Life sciences industry warns levy will force it to scale-back space
A “rocketing” NHS drug levy will cost the sector £3.3bn next year, up from £563m last year
-
Plans submitted for Canary Wharf lab tower
The 823,000 sq ft, 23-storey lab will cost £500m to build and will be the largest lab in Europe
-
Opportunities for Leeds as a digital health and life sciences hub
COMMENT Healthcare and medical technologies are expected to become key growth sectors for Leeds
-
Real estate is key to growth of Scottish life sciences industry
Investment and risk appetite named as missing ingredients of success
-
Survey reveals key features to retain science park tenants
Occupiers want to be in an “ecosystem” and have their business needs fulfilled
-
Partners Group eyes UK life sciences debut
Private equity firm begins talks with developers in search for UK life sciences foothold
-
Oxford Properties expands into French life sciences market
The firm teams with Novaxia for acquisition of Biocitech
-
GSK closes sale of Stevenage life sciences site
UBS and Reef propose £900m investment into new facilities
-
Ancora L&G buys first US tech site
Partners add first 128,000 sq ft lab to platform
-
Nexus Bioquest establishes Bristol hub
Firm signs 10-year lease for lab-enabled office